Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination.

Cellular and Molecular Life Sciences : CMLS
Thomas R ReichMaja T Tomicic

Abstract

To clarify whether differential compartmentalization of Survivin impacts temozolomide (TMZ)-triggered end points, we established a well-defined glioblastoma cell model in vitro (LN229 and A172) and in vivo, distinguishing between its nuclear and cytoplasmic localization. Expression of nuclear export sequence (NES)-mutated Survivin (SurvNESmut-GFP) led to impaired colony formation upon TMZ. This was not due to enhanced cell death but rather due to increased senescence. Nuclear-trapped Survivin reduced homologous recombination (HR)-mediated double-strand break (DSB) repair, as evaluated by γH2AX foci formation and qPCR-based HR assay leading to pronounced induction of chromosome aberrations. Opposite, clones, expressing free-shuttling cytoplasmic but not nuclear-trapped Survivin, could repair TMZ-induced DSBs and evaded senescence. Mass spectrometry-based interactomics revealed, however, no direct interaction of Survivin with any of the repair factors. The improved TMZ-triggered HR activity in Surv-GFP was associated with enhanced mRNA and stabilized RAD51 protein expression, opposite to diminished RAD51 expression in SurvNESmut cells. Notably, cytoplasmic Survivin could significantly compensate for the viability under RAD51 knoc...Continue Reading

References

Dec 7, 2002·International Journal of Clinical Pharmacology and Therapeutics·B Kaina, M Christmann
Dec 4, 2004·International Journal of Cancer. Journal International Du Cancer·Fengzhi LiDongfeng Tan
Nov 14, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shirley K KnauerRoland H Stauber
Jul 10, 2007·Cancer Research·Roland H StauberShirley K Knauer
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Oct 28, 2008·Journal of Neuro-oncology·Katsuyuki ShiraiTakashi Nakano
Jul 26, 2011·Annals of Neurology·Matthias PreusserRoger Stupp
Aug 20, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sebastian ReichertFranz Rödel
May 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Agustin ChicasScott W Lowe
May 25, 2012·The FEBS Journal·Claudio R Santos, Almut Schulze
Sep 7, 2014·Cellular Signalling·Mingli LiuZhi-gang Xiong
Jan 8, 2015·Cell Cycle·Véronique Gire, Vjekoslav Dulic
Jul 15, 2015·Gerontology·Britta UnruheShirley K Knauer
Dec 19, 2015·Breast Cancer Research and Treatment·Eloïse VéquaudSophie Barillé-Nion
Nov 9, 2016·In Vitro Cellular & Developmental Biology. Animal·Chun-Jie HuangLi-Jun Huo
Jan 6, 2017·Cell Death & Disease·Liping JuWeiping Jia
Jan 13, 2019·Genes·Kelly E Leon, Katherine M Aird
Apr 25, 2019·Cell Reports·Yee Voan TeoTamir Chandra
Jun 30, 2019·Nature Communications·Ken TajimaShyamala Maheswaran
Feb 6, 2020·International Journal of Molecular Sciences·Aleksandra Ellert-MiklaszewskaBozena Kaminska

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

CFX Manager
SPSS
GraphPad Prism
GraphPad
DIVA
DAVID
EdgeR
Graph Pad Prism

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Cancer Biology & Therapy
Leisha A Emens
International Journal of Clinical and Experimental Pathology
Michiko ShintaniShingo Kamoshida
International Journal of Hematology
Xiu Li Cong, Zhong Chao Han
© 2021 Meta ULC. All rights reserved